These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Comparative in vitro antibacterial activities of two new oral cephalosporins, ceftetrame (Ro 19-5247) and cefetamet (Ro 15-8074). Chau PY, Leung YK, Ng WW, Arnold K. Antimicrob Agents Chemother; 1987 Mar; 31(3):473-6. PubMed ID: 3579264 [Abstract] [Full Text] [Related]
6. In vitro activity and beta-lactamase stability of cefmenoxime. Neu HC, Labthavikul P. Antimicrob Agents Chemother; 1982 Aug; 22(2):316-22. PubMed ID: 6100427 [Abstract] [Full Text] [Related]
7. In vitro activity of Ro 15-8074 and Ro 19-5247 in comparison to cefaclor and cefalexin. Simon C. Infection; 1987 Aug; 15(2):122-4. PubMed ID: 3596808 [Abstract] [Full Text] [Related]
8. Antimicrobial activity and beta-lactamase stability of SK&F 88070 compared with other agents. Neu HC, Chin NX, Labthavikul P. Diagn Microbiol Infect Dis; 1986 Mar; 4(3):223-30. PubMed ID: 3485506 [Abstract] [Full Text] [Related]
13. Comparative in vitro activity and beta-lactamase stability of FK482, a new oral cephalosporin. Neu HC, Saha G, Chin NX. Antimicrob Agents Chemother; 1989 Oct; 33(10):1795-800. PubMed ID: 2589845 [Abstract] [Full Text] [Related]
15. BMY-28100, a new oral cephalosporin: antimicrobial activity against nearly 7,000 recent clinical isolates, comparative potency with other oral agents, and activity against beta-lactamase producing isolates. Jones RN, Barry AL. Diagn Microbiol Infect Dis; 1988 Jan; 9(1):11-26. PubMed ID: 3259489 [Abstract] [Full Text] [Related]